CD38 and central nervous system cancer: To elucidate the responsiveness of CCR5+CD38+HLA-DR+CD8+ T cells toward glioma, CD8+ T cells were isolated from HD or patient's PBMCs and then co-cultured with the U87 glioma cell line for 24 h.